Thermo Fisher Scientific Inc. (TMO): Price and Financial Metrics
TMO Price/Volume Stats
| Current price | $544.78 | 52-week high | $603.82 |
| Prev. close | $541.52 | 52-week low | $415.60 |
| Day low | $539.17 | Volume | 1,738,500 |
| Day high | $546.14 | Avg. volume | 1,549,866 |
| 50-day MA | $570.68 | Dividend yield | 0.29% |
| 200-day MA | $528.79 | Market Cap | 207.95B |
TMO Stock Price Chart Interactive Chart >
Thermo Fisher Scientific Inc. (TMO) Company Bio
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues. (Source:Wikipedia)
Latest TMO News From Around the Web
Below are the latest news stories about THERMO FISHER SCIENTIFIC INC that investors may wish to consider to help them evaluate TMO as an investment opportunity.
Thermo Fisher Scientific (TMO) Laps the Stock Market: Here's WhyIn the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $531.65, denoting a +0.37% change from the preceding trading day. |
HSBC Sees Opportunity in These 2 Biopharma Giants Ahead of the 2024 ElectionsThe silly season is upon us. Not the holidays – but the election. We’re less than 11 months out from the Presidential vote, and the first primary, the Iowa GOP caucus, is less than 30 days away. Election years are the ‘known unknown’ of the US economy. We know they’re coming, we know the results can change everything, we know that every economic sector will react differently – but we never truly know how those changes will shake out. This cyclical truth of politics and financial markets informs |
Thermo Fisher (TMO) Unveils CorEvitas Pharmacovigilance PlatformThermo Fisher (TMO) introduces the CorEvitas pharmacovigilance platform for clinical research registries. |
Thermo Fisher Scientific's (NYSE:TMO) investors will be pleased with their impressive 139% return over the last five yearsThe most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if... |
Thermo Fisher's (TMO) PPD Business Backs BARDA's Clinical TrialThermo Fisher's (TMO) PPD clinical research business is selected by BARDA to support the Phase II platform clinical trial to treat ARDS. |
TMO Price Returns
| 1-mo | -6.74% |
| 3-mo | -1.20% |
| 6-mo | 18.12% |
| 1-year | -4.45% |
| 3-year | 14.19% |
| 5-year | 112.77% |
| YTD | 2.70% |
| 2023 | -3.36% |
| 2022 | -17.29% |
| 2021 | 43.54% |
| 2020 | 43.72% |
| 2019 | 45.55% |
TMO Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching TMO
Want to do more research on Thermo Fisher Scientific Inc's stock and its price? Try the links below:Thermo Fisher Scientific Inc (TMO) Stock Price | Nasdaq
Thermo Fisher Scientific Inc (TMO) Stock Quote, History and News - Yahoo Finance
Thermo Fisher Scientific Inc (TMO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...